This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sutjipto, S Articles by Marx, P A Search for Related Content PubMed PubMed Citation Articles by Sutjipto, S Articles by Marx, P A

 Previous Article  |  Next Article 

J Virol. 1990 May; 64(5): 2290-2297

Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.

S Sutjipto, N C Pedersen, C J Miller, M B Gardner, C V Hanson, A Gettie, M Jennings, J Higgins and P A Marx

California Primate Research Center, University of California, Davis 95616.

ABSTRACT

Eight rhesus macaques were immunized four times over a period of 8 months with a psoralen-UV-light-inactivated whole simian immunodeficiency virus vaccine adjuvanted with threonyl muramyl dipeptide. Eight unvaccinated control animals received adjuvant alone. Only the vaccinated animals made antibodies before challenge exposure to the viral core and envelope as determined by Western blotting (immunoblotting) and virus-neutralizing antibodies. Ten days after the final immunization, one-half of the vaccinated and nonvaccinated monkeys were challenged exposed intravenously (i.v.) and one-half were challenge exposed via the genital mucosa with virulent simian immunodeficiency virus. All of the nonvaccinated control monkeys became persistently infected. In spite of preexisting neutralizing antibodies and an anamnestic antibody response, all of the immunized monkeys also became persistently infected. However, there was evidence that the clinical course in immunized i.v. infected animals was delayed. All four mock-vaccinated i.v. challenge-exposed animals died with disease from 3 to 9 months postchallenge. In contrast, only one of four vaccinated i.v. challenge-exposed monkeys had died by 11 months postchallenge.

---

J Virol. 1990 May; 64(5): 2290-2297

This article has been cited by other articles:

• Benlhassan-Chahour, K., Penit, C., Dioszeghy, V., Vasseur, F., Janvier, G., Riviere, Y., Dereuddre-Bosquet, N., Dormont, D., Le Grand, R., Vaslin, B. (2003). Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy. J. Virol. 77: 12479-12493 [Abstract] [Full Text]  
• Buge, S. L., Murty, L., Arora, K., Kalyanaraman, V. S., Markham, P. D., Richardson, E. S., Aldrich, K., Patterson, L. J., Miller, C. J., Cheng, S.-M., Robert-Guroff, M. (1999). Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251. J. Virol. 73: 7430-7440 [Abstract] [Full Text]  
• McChesney, M. B., Collins, J. R., Lu, D., Lu, X., Torten, J., Ashley, R. L., Cloyd, M. W., Miller, C. J. (1998). Occult Systemic Infection and Persistent Simian Immunodeficiency Virus (SIV)-Specific CD4+-T-Cell Proliferative Responses in Rhesus Macaques That Were Transiently Viremic after Intravaginal Inoculation of SIV. J. Virol. 72: 10029-10035 [Abstract] [Full Text]  
• Miller, C. J., Marthas, M., Greenier, J., Lu, D., Dailey, P. J., Lu, Y. (1998). In Vivo Replication Capacity Rather Than In Vitro Macrophage Tropism Predicts Efficiency of Vaginal Transmission of Simian Immunodeficiency Virus or Simian/Human Immunodeficiency Virus in Rhesus Macaques. J. Virol. 72: 3248-3258 [Abstract] [Full Text]  
• Marx, P., Compans, R., Gettie, A, Staas, J., Gilley, R., Mulligan, M., Yamshchikov, G., Chen, D, Eldridge, J. (1993). Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260: 1323-1327 [Abstract]  
• Bolognesi, D. P. (1991). AIDS Vaccines: Progress and Unmet Challenges. ANN INTERN MED 114: 161-162 [Abstract]